🚨🇷🇺💉Russia's cancer vaccine — the world's FIRST — could begin reaching patients within A FEW months.
Here's why experts are calling it revolutionary:🧵
Here's why experts are calling it revolutionary:🧵
💥 IMMUNE MARKSMAN
The breakthrough drug “trains” the immune system to recognize and destroy tumor-specific antigens — helping eliminate remaining cancer cells and prevent metastasis or recurrence.
Think of it as your immune system’s private sniper team.
2/8
The breakthrough drug “trains” the immune system to recognize and destroy tumor-specific antigens — helping eliminate remaining cancer cells and prevent metastasis or recurrence.
Think of it as your immune system’s private sniper team.
2/8
🫡 TOTAL PERSONALIZATION
The vaccine is fully personalized, based on a patient’s own tumor’s genetic data.
Doctors extract a sample of the tumor → decode its antigens → create a tailored mRNA shot to target exactly those cells.
3/8
The vaccine is fully personalized, based on a patient’s own tumor’s genetic data.
Doctors extract a sample of the tumor → decode its antigens → create a tailored mRNA shot to target exactly those cells.
3/8
🔥 MULTIPURPOSE MATTERS
The project focuses first on melanoma patients, due to the cancer’s high immunogenicity (response to immune treatment).
But trials could soon expand to other cancers — breast, lung, pancreatic, and more.
4/8
The project focuses first on melanoma patients, due to the cancer’s high immunogenicity (response to immune treatment).
But trials could soon expand to other cancers — breast, lung, pancreatic, and more.
4/8
💥 AI-BACKED
And it’s fast:
AI analyzes each tumor and generates a custom “blueprint” — allowing specialists to produce a personalized vaccine in just about a week.
5/8
And it’s fast:
AI analyzes each tumor and generates a custom “blueprint” — allowing specialists to produce a personalized vaccine in just about a week.
5/8
😍 BUILT BY TOP SCIENCE TEAMS
Developed by the Gamaleya Institute of Epidemiology & Microbiology (creators of Sputnik V) in cooperation with Russia’s leading oncology institutions:
▪️ Hertsen Research Institute
▪️ Blokhin Cancer Center
6/8
Developed by the Gamaleya Institute of Epidemiology & Microbiology (creators of Sputnik V) in cooperation with Russia’s leading oncology institutions:
▪️ Hertsen Research Institute
▪️ Blokhin Cancer Center
6/8
🔥 PROMISING EARLY RESULTS
In mice with melanoma, trials showed strong antitumor effects, according to Gamaleya’s director, Alexander Gintsburg.
7/8
In mice with melanoma, trials showed strong antitumor effects, according to Gamaleya’s director, Alexander Gintsburg.
7/8
😎 WORLD AWAITS
If successful in human trials, this could be a game-changer for global oncology — shifting treatment from one-size-fits-all to bespoke immune precision strikes.
8/8
If successful in human trials, this could be a game-changer for global oncology — shifting treatment from one-size-fits-all to bespoke immune precision strikes.
8/8
• • •
Missing some Tweet in this thread? You can try to
force a refresh
